Literature DB >> 29671174

Increased overall survival after introduction of structured bedside consultation in Staphylococcus aureus bacteraemia.

Maud B P A Ariaans1, Elisabeth A Roovers2, Mark A A Claassen1, Robert-Jan Hassing1, Caroline M A Swanink3, Elisabeth H Gisolf4.   

Abstract

Staphylococcus aureus bacteraemia (SAB) is a common and severe disease. In 2012, a structured bedside consultation (SBC) was introduced at Rijnstate Hospital. We analysed the effect of this SBC on the overall survival of patients with SAB and the effect on the diagnostic workup. We performed a retrospective cohort study, including all patients over 18 years with SAB from 2009 until 2017. The cases preceding versus those after implementation of SBC in 2012 were compared. In total, 613 episodes of SAB were analysed: 234 cases before and 379 cases since SBC. In 484 patients at risk for a complicated course, there was no significant difference in the 30-day survival (77 versus 82%, p = 0.18); however, an increase in 365-day survival was seen (56 versus 64%, p = 0.05). Overall, more patients received adequate therapy, both in the first 2 weeks (67.8 versus 86.7%, p < 0.001), as in complicated SAB (70.5 versus 93.2%, p < 0.001). In 21% of patients with transoesophageal echocardiogram (TEE) following a negative or inconclusive TTE, endocarditis was diagnosed. In patients at risk for complicated SAB, the PET scan revealed a metastatic infection which was not clinically suspected in 65% of positive PET scans. Structured bedside consultation is associated with a better 365-day survival in patients at risk for complicated SAB. Moreover, the additional value of TEE and the PET scan was shown. We strongly advise compliance to SBC in all patients at risk for complicated SAB and the use of both TEE and PET scans in these patients. Even in uncomplicated SAB, TEE or PET scan can reveal metastatic infections.

Entities:  

Keywords:  365-day overall survival; PET scan; Staphylococcus aureus bacteraemia; Structured bedside consultation; Transoesophageal echocardiography

Mesh:

Year:  2018        PMID: 29671174     DOI: 10.1007/s10096-018-3239-1

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  [Evaluation of diagnosis and therapy of Staphylococcus aureus bacteraemia: recommended minimum treatment duration of 2 weeks not always met].

Authors:  Gijs W D Landman; Jolande W Bouwhuis; Peter Bloembergen; Jan T M van der Meer; Paul H P Groeneveld
Journal:  Ned Tijdschr Geneeskd       Date:  2011

Review 2.  Infectious disease consultation for Staphylococcus aureus bacteremia - A systematic review and meta-analysis.

Authors:  Monique Vogel; Roland P H Schmitz; Stefan Hagel; Mathias W Pletz; Nico Gagelmann; André Scherag; Peter Schlattmann; Frank M Brunkhorst
Journal:  J Infect       Date:  2015-10-09       Impact factor: 6.072

3.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

Review 4.  Clinical management of Staphylococcus aureus bacteremia: a review.

Authors:  Thomas L Holland; Christopher Arnold; Vance G Fowler
Journal:  JAMA       Date:  2014-10-01       Impact factor: 56.272

Review 5.  Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.

Authors:  Emelie C Schuts; Marlies E J L Hulscher; Johan W Mouton; Cees M Verduin; James W T Cohen Stuart; Hans W P M Overdiek; Paul D van der Linden; Stephanie Natsch; Cees M P M Hertogh; Tom F W Wolfs; Jeroen A Schouten; Bart Jan Kullberg; Jan M Prins
Journal:  Lancet Infect Dis       Date:  2016-03-03       Impact factor: 25.071

6.  Staphylococcus aureus bacteremia: the cost-effectiveness of long-term therapy associated with infectious diseases consultation.

Authors:  J Lundberg; M D Nettleman; M Costigan; S Bentler; J Dawson; R P Wenzel
Journal:  Clin Perform Qual Health Care       Date:  1998 Jan-Mar

7.  Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia.

Authors:  Timothy C Jenkins; Connie S Price; Allison L Sabel; Philip S Mehler; William J Burman
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

8.  Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity.

Authors:  Olivier Lesens; Cédric Methlin; Yves Hansmann; Véronique Remy; Martin Martinot; Colm Bergin; Pierre Meyer; Daniel Christmann
Journal:  Infect Control Hosp Epidemiol       Date:  2003-12       Impact factor: 3.254

9.  Impact of routine bedside infectious disease consultation on clinical management and outcome of Staphylococcus aureus bacteraemia in adults.

Authors:  R B Saunderson; T Gouliouris; E K Nickerson; E J P Cartwright; A Kidney; S H Aliyu; N M Brown; D Limmathurotsakul; S J Peacock; M E Török
Journal:  Clin Microbiol Infect       Date:  2015-05-29       Impact factor: 8.067

Review 10.  The Impact of Infectious Disease Specialist Consultation for Staphylococcus aureus Bloodstream Infections: A Systematic Review.

Authors:  Julie Paulsen; Erik Solligård; Jan Kristian Damås; Andrew DeWan; Bjørn Olav Åsvold; Michael B Bracken
Journal:  Open Forum Infect Dis       Date:  2016-03-01       Impact factor: 3.835

View more
  3 in total

1.  Development of quality indicators for the management of Staphylococcus aureus bacteraemia.

Authors:  Jaap Ten Oever; Joëll L Jansen; Thomas W van der Vaart; Jeroen A Schouten; Marlies E J L Hulscher; Annelies Verbon
Journal:  J Antimicrob Chemother       Date:  2019-11-01       Impact factor: 5.790

2.  Prediction Rules for Ruling Out Endocarditis in Patients With Staphylococcus aureus Bacteremia.

Authors:  Thomas W van der Vaart; Jan M Prins; Robin Soetekouw; Gitte van Twillert; Jan Veenstra; Bjorn L Herpers; Wouter Rozemeijer; Rogier R Jansen; Marc J M Bonten; Jan T M van der Meer
Journal:  Clin Infect Dis       Date:  2022-04-28       Impact factor: 20.999

3.  Early differentiation between uncomplicated and complicated Staphylococcus aureus bacteraemia: Potential value and limitations of a clinical risk score.

Authors:  Merel M C Lambregts; Eva B D Molendijk; Soufian Meziyerh; Emile F Schippers; Nathalie M Delfos; Masja Leendertse; Alexandra T Bernards; Leo G Visser; Olaf M Dekkers; Mark G J de Boer
Journal:  Int J Clin Pract       Date:  2020-07-14       Impact factor: 3.149

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.